Gerger, A; Riedl, J; Hasenleithner, SO; Höfler, G; Jahn, S; Esterl, T; Jost, PJ; Speicher, MR; Heitzer, E.
Identifizierung von Tumorprädispositionen im Rahmen von klinischen ctDNA-Tests
ÖGH Jahrestagung; Sep 29, 2022; Graz, AUSTRIA. 2022.
[Oral Communication]
Suppan, C; Zhou, Q; Jahn, S; Graf, R; Klocker, EV; Terbuch, A; Kashofer, K; Posch, F; Gerritsmann, H; Dandachi, N; Heitzer, E; Balic, M
Comparison of liquid biopsy and tissue based detection of PIK3CAmutations in HR positive metastatic breast cancer patients
CANCER RES. 2021; 81(4):
[Poster]
Web of Science
Christoph Suppan, Qing Zhou, Stephan Jahn, Ricarda Graf, Eva Valentina Klocker, Angelika Terbuch, Karl Kashofer, Florian Posch, Hanno Gerritsmann, Nadia Dandachi, Ellen Heitzer, Marija Balic
Comparison of liquid biopsy and tissue based detection ofPIK3CAmutations in HR positive metastatic breast cancer patients.
SABCS 2020. 2020; -SABCS 2020; DEC 8-11, 2020; SAN ANTONIO, TEXAS, USA.
[Poster]
Gerger, A; Riedl, JM; Perakis, S; Pregartner, G; Scheipner, L; Posch, F; Groller, K; Kashofer, K; Jahn, SW; Bauernhofer, T; Pichler, M; Stoger, H; Berghold, A; Hofler, G; Speicher, M; Heitzer, E
Profiling of circulating tumour DNA for treatment selection in patients with advanced and refractory carcinoma: A prospective, two-stage phase II individualized cancer treatment trial.
ANN ONCOL. 2020; 31: S1095-S1096.-ESMO Virtual Congress; SEP 19-OCT 18, 2020; ELECTR NETWORK.
Doi: 10.1016/j.annonc.2020.08.1331
[Onlinepräsentation]
[OPEN ACCESS]
Web of Science
FullText
FullText_MUG
Kirchhoff, E; Petru, E; Tamussino, K; Jahn, SW; Regitnig, P
Mucinous Ovarian Cancer: A separate Entity.
GEBURTSH FRAUENHEILK. 2020; 80(4):438-439.-XXVIII. Wissenschaftliche Tagung der Arbeitsgemeinschaft für Gynäkologische Onkologie (AGO) der OEGGG 2020
; APR 23-25,2020; Salzburg, AUSTRIA.
Doi: 10.1055/s-0039-3403410
[Poster]
Web of Science
FullText
FullText_MUG
Riedl, J; Perakis, S; Pregartner, G; Scheipner, L; Posch, F; Groller, K; Kashofer, K; Jahn, SW; Bauernhofer, T; Pichler, M; Stoger, H; Berghold, A; Hofler, G; Speicher, M; Heitzer, E; Gerger, A
Individualized cancer treatment based on molecular profiling of circulating tumor DNA in patients with advanced and refractory carcinoma: a prospective phase II trial.
ONCOL RES TREAT. 2020; 43(SUPPL 4):249-249.-DGHO Jahrestagung; 09.10. -11.10.2020; Basel (virtueller Kongress).
[Oral Communication]
Web of Science
Taumberger, N; Greimel, P; Schütz, A; Hochstätter, R; Eisnecker, K; Nanda, M; Kurleto, M; Bracic, T; Jahn, S; Tamussino, K; Klaritsch, P
Arteriovenous malformation following uterine scar pregnancy.
Ultrasound Obstet Gynecol 2020; 56 (Suppl. 1): 57–378.. 2020; 56(267):268--30th ISUOG Virtual World Congress; OKT 16-18; London, UK.
Klec, C; Schwarzenbacher, D; Resel, M; Rinner, B; Haybaeck, J; Höfler, G; Jahn, SW; Bauernhofer, T; Stöger, H; Pichler, M
miR-1287-5p inhibits triple negative breast cancer growth by interacting with phosphoinositide 3-kinase CB, thereby sensitizing cells for PI3Kinase inhibitors
ÖGHO Frühjahrstagung 2019. 2019; -ÖGHO Frühjahrstagung; 11.-13.April; Linz, AUSTRIA.
[Poster]
Klec, C; Schwarzenbacher, D; Resel, M; Rinner, B; Haybaeck, J; Höfler, G; Jahn, SW; Bauernhofer, T; Stöger, H; Pichler, M
miR-1287-5p inhibits triple negative breast cancer growth by interacting with phosphoinositide 3-kinase CB, thereby sensitizing cells for PI3Kinase inhibitors
ÖGHO Frühjahrstagung 2019. 2019; -ÖGHO Frühjahrstagung 2019; 11.-13.April; Linz, AUSTRIA.
[Oral Communication]
Terzic, J; Fillafer, F; Posch, F; Pichler, R; Seles, M; Niedersuss-Beke, D; Tinchon, C; Loidl, W; Pichler, M; Jahn, S; Stoger, H; Bauernhofer, T;
Lymphopenia impairs response to 1st-line tyrosine kinase inhibitor therapy in patients with metastatic clear-cell renal cell carcinoma and modulates the relative efficacy of sunitinib and pazopanib
WIEN KLIN WOCHENSCHR. 2019; 131: S447-S447.-Frühjahrstagung der OeGHO; APR 11-13, 2019; Linz, AUSTRIA.
[Poster]
Web of Science
FullText
Wienerroither, V; Wolf, G. Simon, A; Jahn, SW; Mischinger, HJ; Mache, C
Primary hyperparathyroidism in a 14-year-old male: A case report
Keine. 2019; -60. Österreichischer Chirurgenkongress; JUN 19-21, 2019; Innsbruck, AUSTRIA.
[Poster]
Terzic, J; Fillafer, F; Posch, F; Pichler, R; Seles, M; Pichler, M; Jahn, S; Stöger, H; Bauernhofer, T
Lymphopenia impairs response to 1st-line therapy with
sunitinib and pazopanib in patients with metastatic clear-cell
renal cell carcinoma.
Oncology Research
and Treatment . 2018; 41(Suppl4):42-43.-Jahrestagung der Deutschen, Österreichischen und Schweizerischen Gesellschaften für Hämatologie und Medizinische Onkologie,; SEP 28- OCT 2, 2018; Vienna, AUSTRIA. (ISBN: 978-3-318-06425-4 )
[Oral Communication]
Web of Science
FullText
Ulz, P; Thallinger, GG; Auer, M; Graf, R; Kashofer, K; Jahn, SW; Abete, L; Pristauz, G; Petru, E; Geigl, JB; Heitzer, E; Speicher, MR
Nucleosome association of cell-free DNA informs about gene expression
8th international Gene Quantification Event
Symposium & Industrial Exhibition & Application Workshops
; APR 3-7, 2017; Freising-Weihenstephan, GERMANY. 2017.
[Oral Communication]
Ulz, P; Thallinger, GG; Auer, M; Graf, R; Kashofer, K; Jahn, SW; Abete, L; Pristauz, G; Petru, E; Geigl, JB; Heitzer, E; Speicher, MR
Inferring expressed genes by whole-genome sequencing of plasma DNA
28. Jahrestagung der Deutschen Gesellschaft für Humangenetik ; MAR 29-31, 2017; Bochum, GERMANY. 2017.
[Oral Communication]
Ulz, P; Thallinger, GG; Auer, M; Graf, R; Kashofer, K; Jahn, SW; Abete, L; Pristauz, G; Petru, E; Geigl, JB; Heitzer, E; Speicher, MR
Nucleosome occupancy of cfDNA informs about gene expression
10th CNAPS International Symposium ; SEP 20-22, 2017; Montpellier, FRANCE. 2017.
[Oral Communication]
Heitzer, E; Ulz, P; Thallinger, GG; Auer, M; Kashofer K; Jahn, SW; Abete L; Pristauz, G; Petru, E; Geigl,JB; Speicher, MR.
Inferring expressed genes by whole-genome sequencing of plasma DNA.
https://ep70.eventpilot.us/web/planner.php?id=ASHG16. 2016; -ASHG 2016; OCT 18-22, 2016; vancouver Kanada.
[Poster]
FullText
Kashofer, K; Jahn, S; Halbwedl, I; Hoetler, G
Beyond BRCA-HRD scoring using Affymetrix Oncoscan microarrays
VIRCHOWS ARCH. 2016; 469: S203-S203.
[Poster]
Web of Science
Singer, CF; Filipits, M; Jahn, S; Abete, L; Jakesz, R; Greil, R; Bauernhofer, T; Kwasny, W; Seifert, M; Fitzal, F; Schmitt, M; Moinfar, F; Gnant, M
Stromel co-expression of urokinase-type plasminogen activator (uPA) and plasminogen activator Inhibitor (PAI-1) protein by IHC predicts poor disease outcome in endocrine-treated postmenopausal patients with receptor-positive early breast cancer
CANCER RES. 2016; 76: -38th Annual CTRC-AACR San Antonio Breast Cancer Symposium; DEC 08-12, 2015; San Antonio, TX.
Doi: 10.1158/1538-7445.SABCS15-P2-08-21
[Poster]
Web of Science
FullText
FullText_MUG
Ulz, P; Thallinger, GG; Auer, M; Graf, R; Kashofer, K; Jahn, SW; Abete, L; Pristauz, G; Petru, E; Geigl, JB; Heitzer, E; Speicher, MR
Inferring expressed genes by whole-genome sequencing of plasma DNA.
16. Jahrestagung der Österreichischen
Gesellschaft für Humangenetik; SEP 30, 2016; Vienna, AUSTRIA. 2016.
[Oral Communication]
Jahn, S
Prädiktive Testung beim Ovarialkarzinom, BRCA und BRCA-ness.
Update Molekularpathologie; NOV 18, 2015; Grau. 2015.
[Oral Communication]
Jahn, S
Molecular analysis in colon cancer.
Advances in Diagnostic Molecular Pathology; JUL 13 - 14, 2015; Graz, AUSTRIA. 2015.
[Oral Communication]
Jahn, S
Prädiktive Testung beim Ovarialkarzinom, BRCA und BRCA-ness.
Molecular analysis in Colon cancer.; JUL 13 - 14, 2015; Graz. 2015.
[Oral Communication]
Kammerer, S; Jahn, S; Winter, E; Sokolowski, A; Hackl, H; Platzer, D; Peintinger, F; Schreibmayer, W; Bauernhofer, T
GIRK1: a new prognostic biomarker for estrogen receptor positive breast cancer
OeGHO Frühjahrstagung 2015; APR 23-25, 2015; Salzburg, AUSTRIA. 2015.
[Poster]
Kammerer, S; Sokolowski, A; Hackl, H; Platzer, D; Jahn, SW; Peintinger, F; Symmans, F; Schreibmayer, W; Bauernhofer, T.
GIRK1 overexpression correlates with ER positive breast cancer subtypes and is associated with poor prognosis.
Annals of Oncology 2015;26(Supplement 3):15-24. 2015; 26(Supplement 3): 22--IMPAKT 2015 Breast Cancer Meeting; MAY 7-9, 2015; Brussels, BELGIUM.
[Poster]
Matak, A; Jahn, S; Viertler, C; Thuringer, A; Halbwedl, I; Langner, C; Hoefler, G; Kashofer, K
Genetic heterogeneity of colorectal carcinoma in NGS analysis: A complication for molecular diagnosis?
VIRCHOWS ARCH. 2015; 467: S166-S167.-European Congress of Pathology; SEP 5-9, 2015; Belgrade, SERBIA.
[Poster]
Web of Science
Singer, CF; Filipits, M; Jahn, S; Abete, L; Jakesz, R; Greil, R; Bauernhofer, T; Kwasny, W; Seifert, M; Fitzal, F; Schmitt, M; Moinfar, F; Gnant, M
Influence of immunohistological detection of intratumoral urokinase-type plasminogen activator (uPA) on disease outcome in endocrine-treated postmenopausal patients with hormone receptor-positive early breast cancer.
J CLIN ONCOL. 2015; 33(15):
Doi: 10.1200/jco.2015.33.15_suppl.551
[Poster]
Web of Science
FullText
FullText_MUG
Ulz, P; Auer, M; Belic, J; Lafer I; Jahn, SW; Pristauz, G; Heidary, M; Schwarzbraun, T; Fischereder K; Gerger, A; Hoefler; G; Augustin, H; Bauernhofer, T; Petru, E; Heitzer, E; Geigl, JB; Speicher, MR
Circulating tumor DNA sequencing reveals cancer driver genes and their plasticity
in focal amplifications
Medizinische Genetik. 2015; 27(1):79-109.-26. Jahrestagung der Deutschen Gesellschaft für Humangenetik gemeinsam mit der Österreichischen Gesellschaft für Humangenetik und der Schweizerischen Gesellschaft für Medizinische Genetik; APR 15-17, 2015; Graz, AUSTRIA.
[Oral Communication]
FullText
Auer, M; Heitzer, E; Ulz, P; Petru, E; Pristauz, G; Jahn, S; Speicher, MR; Geigl, JB
Whole-genome sequencing of plasma DNA reveals frequently occurring copy number changes in patients with metastatic breast cancer
http://gfhev.de/de/kongress/GfH_Tagung_2014_Abstractbook.pdf. 2014; -25. Jahrestagung der Deutschen Gesellschaft für Humangenetik; MARCH 19-21, 2014; Essen, GERMANY.
[Poster]
Auer, M; Heitzer, E; Ulz, P; Pristauz, G; Petru, E; Jahn, S; Speicher, MR; Geigl JB
Low coverage whole-genome sequencing of plasma DNA reveals frequently occurring copy number changes in patients with metastatic breast cancer
http://eacr23.eacr.org/. 2014; -23rd Biennal Congress of the European Association of Cancer Research; JULY 4 - 8, 2014; Munich, GERMANY.
[Poster]
Auer, M; Heitzer, E; Ulz, P; Pristauz, G; Petru, E; Jahn, S; Speicher, MR; Geigl, JB;
Whole-genome sequencing of plasma DNA reveals frequently occurring copy number changes in patients with metastatic breast cancer.
EUR J CANCER. 2014; 50: S153-S153.-EACR; München.
Doi: 10.1016/S0959-8049(14)50562-X
[Oral Communication]
Web of Science
FullText
FullText_MUG
Kammerer, S; Sokolowski, A; Hackl, H; Jahn, S; Asslaber, M; Symmans, F; Peintinger, F; Regitnig, P; Schreibmayer, W; Bauernhofer, T
OVEREXPRESSION OF G PROTEIN-ACTIVATED INWARD RECTIFIER POTASSIUM CHANNEL 1 (GIRK1) IS ASSOCIATED WITH LYMPH NODE METASTASIS AND POOR PROGNOSIS IN BREAST CANCER
ANN ONCOL. . 2014; 25: -IMPAKT Breast Cancer Conference; MAY 08-10, 2014; Brussels, BELGIUM.
Doi: 10.1093/annonc/mdu066.21
[Poster]
Web of Science
FullText
FullText_MUG
Kammerer, S; Sokolowski, A; Hackl, H; Platzer, D; Jahn, S; Asslaber, M; Schreibmayer, W; Bauernhofer, T
Overexpression of GIRK1 is associated with lymph node metastasis and poor prognosis in breast cancer.
ZMF 10th Anniversary - Scientific Symposium.; JUL 17-18, 2014; Graz, AUSTRIA. 2014.
[Oral Communication]
Kammerer, S; Sokolowski, A; Hackl, H; Platzer, D; Jahn, S; Schreibmayer, W; Bauernhofer, T
GIRK1 overexpression correlates with ER positive breast cancer subtypes and is associated with poor prognosis.
Doctoral Day 2014; DEC 10, 2014; Graz, AUSTRIA. 2014.
[Poster]
Kammerer, S; Sokolowski, A; Hackl, H; Platzer, D; Jahn, S; Schreibmayer, W; Bauernhofer, T
G protein-activated inward rectifier potassium channel 1 overexpression is associated with lymph node metastasis and poor prognosis in breast cancer.
ÖGMBT 6th Annual Meeting; SEPT 15-18, 2014; Vienna, AUSTRIA. 2014.
[Oral Communication]
Kammerer, S; Sokolowski, A; Hackl, H; Platzer, D; Rezania, S; Jahn, S; Asslaber, M; Regitnig, P; Schreibmayer, W; Bauernhofer, T
G protein-activated inward rectifier potassium channel 1 (GIRK1) expression in breast cancer.
Gordon Research Conference; JUN 8-13, 2014; Lucca (Barga), ITALY. 2014.
[Poster]
Auer, M; Fondi, M; Heitzer, E; Pristauz, G; Petru, E; Jahn, S; Gasch, C; Pantel, K; Riethdorf, S; Speicher, MR; Geigl, JB
High-resolution molecular characterization of circulating cell-free DNA and circulating tumor cells of patients with metastatic breast cancer
7. Forschungsforum der österreichsichen Fachhochschulen; APRIL 3-4, 2013; Dornbirn, AUSTRIA. 2013.
[Poster]
Auer, M; Heitzer, E; Ulz, P; Pristauz, G; Petru, E; Jahn, S; Lafer, I; Pantel, K; Riethdorf, S; Speicher, MR; Geigl, JB
Complex tumor genomes inferred from plasma DNA of patients with metastatic breast cancer by whole-genome sequencing.
http://www.ecco-org.eu. 2013; -The European Cancer Congress 2013 (ECCO17 - ESMO38 - ESTRO32) ; SEP 27 - OCT 1, 2013; Amsterdam, NETHERLANDS.
[Keynote lecture]
Auer, M; Heitzer, E; Ulz, P; Pristauz, G; Petru, E; Jahn, S; Lafer, I; Pantel, K; Speicher, MR; Geigl, JB
Complex tumor genomes inferred from plasma DNA of patients with metastatic breast cancer by whole-genome sequencing
EUR J CANCER. 2013; 49: S399-S399.-17th ECCO / 38th ESMO / 32nd ESTRO European Cancer Congress on Reinforcing Multidisciplinarity; SEP 27-OCT 01, 2013; Amsterdam, NETHERLANDS.
[Oral Communication]
Web of Science
Auer, M; Ulz, P; Pristauz, G; Petru, E; Jahn, S; Gasch, C; Riethdorf, S; Pantel, K; Geigl, JB; Speicher, MR; Heitzer, E
High-resolution molecular characterization of circulating cell-free DNA and circulating tumor cells of patients with metastatic breast cancer.
http://gfhev.de/de/kongress/GfH_Tagung_2013_Abstractbook.pdf. 2013; -24. Jahrestagung
der Deutschen Gesellschaft für Humangenetik ; MAR 20-22,2013; Dresden, GERMANY.
[Keynote lecture]
Jahn, SW
Fallpräsentation: Multiple Gastrointestinale Stromatumore bei c-Kit Keimbahnmosaik
12. Onkologische Wintergespräche; JAN 18-19; Vienna, Austria. 2013.
[Oral Communication]
Kammerer, S; Sokolowski, A; Rezania, S; Gorischek, A; Hackl, H; Malle, E; Jahn, S; Asslaber, M; Schreibmayer, W; Bauernhofer, T
GIRK1 protein expression in primary tumours of breast cancer patients.
Doctoral Day 2013; DEC 9, 2013; Graz, AUSTRIA. 2013.
[Poster]
Jahn, S
Praktische Aspekte des Tests Viennalab.
23. Frühjahrstagung der ÖGP IAP Austria und 10. Gemeinsame Fortbildungstagung für Biomedizinische AnalytikerInnen & Ärzte ; MAR 26-28, 2009; Innsbruck. 2009.
[Oral Communication]
Jahn, S
Immunohistochemistry slide session.
POSTGRADUATE COURSE
MOLECULAR PATHOLOGY OF COLON CANCER
; April 16 18, 2009; Graz. 2009.
[Oral Communication]
Jahn, S
Dickdarmperforation unter Avastin-Therapie.
22. Frühjahrstagung der ÖGP IAP Austria und 9. Gemeinsame Fortbildungstagung für Biomedizinische AnalytikerInnen & Ärzte; MAR 27-29, 2008; Vienna, Austria. 2008.
[Oral Communication]
Jahn, S
Praktische Aspekte des Tests Viennalab.
POSTGRADUATE COURSE
MOLECULAR PATHOLOGY OF COLON CANCER
; April 16 18, 2009; Graz. 2008.
[Oral Communication]
Jahn, S
Immunhistochemie des HNPCC Syndroms.
22. Frühjahrstagung der ÖGP IAP Austria und 9. Gemeinsame Fortbildungstagung für Biomedizinische AnalytikerInnen & Ärzte; MAR 27-29, 2008; Vienna, Austria. 2008.
[Oral Communication]
Jahn, S
Kritische Analyse von Zuweisungen für die Histologie und Aspekte der Qualitätssicherung.
21. Frühjahrstagung der ÖGP/ IAP Austria und 8. Gemeinsame Fortbildungstagung für Biomedizinische AnalytikerInnen und Ärzte; MAR 8-10, 2007; Vienna, Austria. 2007.
[Oral Communication]